Plasmin triggers rapid contraction and degradation of fibroblast-populated collagen lattices.
We examined the role of the serine proteinase plasmin in regulating fibroblast-mediated tissue remodeling during wound healing. As an in vitro model system, collagen lattices were seeded with human dermal fibroblasts, and various concentrations of plasmin were added to the medium of the contracting lattices. Within 16 h, fibroblast-populated collagen lattices treated with plasmin rapidly contracted from approximately 20 mm to less than 2 mm in diameter. Measurements of collagen lattices with radiolabeled collagen indicated that, when these lattices included either fibroblasts or conditioned medium derived from fibroblast-populated collagen lattices, exogenous plasmin induced collagen degradation and rapid lattice contraction. Western blot analyses of conditioned medium demonstrated that fibroblasts in collagen lattices secreted the latent matrix metalloproteinase, MMP-1, which was subsequently cleaved by plasmin. Additionally, rapidlattice contraction and collagen degradation were blocked when collagen lattices were treated simultaneously with plasmin and aprotinin or a tissue inhibitor of metalloproteinases, TIMP-1. These results provide strong evidence that plasmin regulates rapid contraction of collagen lattices by activating fibroblast-secreted MMP-1 that triggers collagen degradation. The findings from this study suggest that fibroblast-populated collagen lattices can be used as an in vitro model system to investigate the mechanisms by which plasmin and cell-secreted plasminogen activators control MMP-1 mediated extracellular lattice degradation and remodeling during wound healing.
Pins
G D
GD
The Shriners Burns Hospital and Surgical Services, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Collins-Pavao
M E
ME
Van De Water
L
L
Yarmush
M L
ML
Morgan
J R
JR
D007611:Aprotinin / Q000494:pharmacology; D002460:Cell Line; D003094:Collagen / Q000378:metabolism*; D005341:Fibrinolysin / Q000502:physiology*; D005347:Fibroblasts / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D020781:Matrix Metalloproteinase 1 / Q000378:metabolism; D008954:Models, Biological; D011480:Protease Inhibitors / Q000494:pharmacology; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000494:pharmacology; D014945:Wound Healing
D011480:Protease Inhibitors; D015842:Serine Proteinase Inhibitors; D019715:Tissue Inhibitor of Metalloproteinase-1; D003094:Collagen; D007611:Aprotinin; D005341:Fibrinolysin; D020781:Matrix Metalloproteinase 1